Humacyte, Inc. Common Stock
$0.59
$0.01 (+1.83%)
$0.57Day Range$0.61
Key Statistics
Market Cap
$159.76M
Shares Outstanding
277.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 27, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$0.57
Day High
$0.61
Day Low
$0.57
Volume
6.99M
VWAP
$0.59
Prev Close
$0.58
Transactions
--
Acc. Volume
--
About Humacyte, Inc. Common Stock
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836184 employees2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713919-313-9633IPO Aug 27, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001818382
- Composite FIGI
- BBG00XPPT7S7
- Share Class FIGI
- BBG00XPPT7T6
- Ticker Root
- HUMA
- SIC Code
- 2836
About Humacyte, Inc. Common Stock (HUMA) Stock
Humacyte, Inc. Common Stock (HUMA) closed the 2026-09-18 session at $0.59, up 1.83% versus the previous close (+0.01). The stock opened at $0.57 and traded between $0.57 and $0.61 during that session. Session trading volume was 7.0M shares. The volume-weighted average price (VWAP) is $0.59.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Humacyte, Inc. Common Stock has a market capitalization of $159.8 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. HUMA is listed on the XNAS exchange. The company employs approximately 184 people. Humacyte, Inc. Common Stock is headquartered in DURHAM, NC. The recorded listing date is 2021-08-27.
On this page you can find market HUMA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.